Ontology highlight
ABSTRACT: Background
A review of Health Canada's post-market surveillance database has revealed that the reporting of adverse events (AEs) following aesthetic injectable treatments is significantly underreported. To increase reporting, investigators have recently developed a novel Electronic Data Capture system: The Global Registry of Adverse Clinical Events (GRACE©).Objective
To identify the incidence of AEs associated with aesthetic injectable treatments.Methods
Aesthetic clinicians from 10 Canadian sites were recruited. Demographic and clinical data were recorded within the database, which included over 45 patient variables.Results
Throughout the active phase of the trial (duration: 27 months), 123,124 injectable treatments were conducted. One hundred an
SUBMITTER: Enright KM
PROVIDER: S-EPMC12304487 | biostudies-literature | 2025 Jan
REPOSITORIES: biostudies-literature